These results were compatible with the inactivation of GSK3β by phosphorylation at Ser 9 (Figure 5B), since GSK3β inhibition was shown to attenuate the invasion of several types of cancer cells by decreasing the secretion and activation of MMP2 [37,38]. The gene discussed is MMP2; the disease is cancer.